A Study to Assess the Effect of Food on the Drug Levels of Admilparant
- Registration Number
- NCT07225647
- Lead Sponsor
- Bristol-Myers Squibb
- Brief Summary
The purpose of this study is to assess the effect of food on the drug levels of Admilparant
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Part 1: Treatment A Admilparant - Part 1: Treatment B Admilparant - Part 2: Treatment C Admilparant - Part 2: Treatment D Admilparant -
- Primary Outcome Measures
Name Time Method Maximum observed plasma concentration (Cmax) Up to 13 days Area under the concentration-time curve from time zero to time of last quantifiable concentration (AUC(0-T)) Up to 13 days Area under the concentration-time curve from time zero extrapolated to infinite time (AUC(INF)) Up to 13 days
- Secondary Outcome Measures
Name Time Method Apparent total body clearance (CLT/F) Up to 13 days Apparent volume of distribution (Vz/F) Up to 13 days Terminal half-life (T-HALF) Up to 13 days Time of maximum observed plasma concentration (Tmax) Up to 13 days Number of participants with adverse events (AEs) Up to 13 days Number of participants with a change in clinical laboratory values Up to 13 days Number of participants with a change in vital sign measurements Up to 13 days Number of participants with a change in physical examination results Up to 13 days Number of participants with a change in 12-lead electrocardiogram (ECG) results Up to 13 days
Trial Locations
- Locations (2)
Local Institution - 0002
🇺🇸Lenexa, Kansas, United States
Local Institution - 0001
🇺🇸Salt Lake City, Utah, United States
Local Institution - 0002🇺🇸Lenexa, Kansas, United StatesSite 0002Contact